JDRF Research

BREAKING NEWS! A CDC advisory committee voted 14-0 recommending the use of the Pfizer/BioNTech COVID-19 vaccine in children ages 5-11. The CDC Director will soon make a recommendation on behalf of the CDC. Stay tuned for more details!

Vertex VX-880 shows promising data from its Phase 1/2 Clinical Trial, including a 91% reduction in daily insulin requirement after 90 days. Learn more: jdrf.org/blog/2021/10/1…

JDRF mourns the loss of T1D researcher Stacey Anderson, M.D. Read about her many contributions to the T1D here: jdrf.org/blog/2021/10/0…

@JDRF is proud to announce the appointment of @ShereefElnahal to the JDRF Research Committee. Learn more here: jdrf.org/press-releases…

Last week, @JDRF and @NIDDKgov brought together the top minds in immunology, material science, bioengineering, transplants and more to discuss keeping transplanted beta cells healthy through immune tolerance and localized immune modulation. Learn more: jdrf.org/blog/2021/08/0…

Good news for the T1D community: @US_FDA has approved Semglee® as the first interchangeable biosimilar insulin product. Learn more at the blog: jdrf.org/blog/2021/07/2…

@JDRF is proud to have supported JDRF T1D Fund portfolio company Protomer Technologies since its inception and is thrilled to hear it has a new home at @LillyPad! t1dfund.org/news/lilly-ann…

Dr. Nikki Farnsworth discusses her research around beta cell death and how she's working to identify potential targets to help prevent beta cell death. #JDRFxADA #ADA2021

Check out our recap of Day 1 of the @AmDiabetesAssn's Scientific Sessions at the link below! #JDRFxADA #ADA2021 ow.ly/rejm50Fj5OJ

Join us at 7pm ET for a Facebook Premiere event featuring key takeaways from Day 1 of The @AmDiabetesAssn's Scientific Sessions. Tune in at facebook.com/myJDRF #JDRFxADA #ADA2021

Elad Sintov discusses his work focuses around building genetic modifications in stem cells as a replacement therapy for type 1 diabetes (T1D). #JDRFxADA #ADA2021

Adriana Migliorini discusses her work, which is focused around understanding immune cells and endocrine cells during human pancreatic development #JDRFxADA #ADA2021

JDRF's Vice President of Research, Dr. Sanjoy Dutta shares what you can expect to learn from The @AmDiabetesAssn's 81st annual Scientific Sessions and how we'll be keeping you updated. #JDRFxADA #ADA2021

At 1pm ET JDRF's Vice President of Research, Dr. Sanjoy Dutta will be giving a preview of what you can expect to learn from the @AmDiabetesAssn 81st Scientific Sessions, and how we'll be keeping you updated! #JDRFxADA #ADA2021

We are proud to announce that Kevan Herold, M.D., C.N.H., Long Professor of Immunobiology and professor of medicine at Yale University, has been named chair of Type 1 Diabetes TrialNet. Congratulations, Dr. Herold! trialnet.org/events-news/bl… @NIDDKgov

JDRF Vice President of Research, Sanjoy Dutta, Ph.D., congratulates Kevan Herald, M.D. on his appointment as the new TrialNet Chair. Read more: jdrf.org/press-releases…

JDRF applauds the U.S. Food and Drug Administration’s (FDA) Advisory Committee positive recommendation in support of approval of teplizumab for those at risk for developing clinical T1D. Learn more here: ow.ly/kt0f50EXfnB

Life with T1D is tough. That's why JDRF is observing Mental Health Awareness Month and supporting psychosocial health issues in people with T1D through the JDRF Behavioral Health and Psychology Program. Learn more at the blog: jdrf.org/blog/2021/05/2…

We also want to thank and celebrate everyone who has been in a clinical trial. You are heroes!

May 20th is Clinical Trials Day! Today, we want to raise awareness about them and the pivotal role they play in bringing new therapies into the hands of the T1D community. Learn more, including how to find a clinical trial, at the blog. jdrf.org/blog/2021/05/2…